JP2002537292A5 - - Google Patents

Download PDF

Info

Publication number
JP2002537292A5
JP2002537292A5 JP2000599745A JP2000599745A JP2002537292A5 JP 2002537292 A5 JP2002537292 A5 JP 2002537292A5 JP 2000599745 A JP2000599745 A JP 2000599745A JP 2000599745 A JP2000599745 A JP 2000599745A JP 2002537292 A5 JP2002537292 A5 JP 2002537292A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
optionally substituted
hydrogen
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000599745A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002537292A (ja
Filing date
Publication date
Priority claimed from GBGB9903532.1A external-priority patent/GB9903532D0/en
Application filed filed Critical
Priority claimed from PCT/GB2000/000553 external-priority patent/WO2000049005A1/en
Publication of JP2002537292A publication Critical patent/JP2002537292A/ja
Publication of JP2002537292A5 publication Critical patent/JP2002537292A5/ja
Pending legal-status Critical Current

Links

JP2000599745A 1999-02-16 2000-02-16 二環化合物およびそれらのインテグリン受容体リガンドとしての使用 Pending JP2002537292A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9903532.1A GB9903532D0 (en) 1999-02-16 1999-02-16 Chemical compounds
US14144599P 1999-06-29 1999-06-29
US60/141,445 1999-06-29
US9903532.1 1999-06-29
PCT/GB2000/000553 WO2000049005A1 (en) 1999-02-16 2000-02-16 Bicyclic compounds and their use as integrin receptor ligands

Publications (2)

Publication Number Publication Date
JP2002537292A JP2002537292A (ja) 2002-11-05
JP2002537292A5 true JP2002537292A5 (cg-RX-API-DMAC7.html) 2007-04-05

Family

ID=26315145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000599745A Pending JP2002537292A (ja) 1999-02-16 2000-02-16 二環化合物およびそれらのインテグリン受容体リガンドとしての使用

Country Status (11)

Country Link
US (1) US6593354B2 (cg-RX-API-DMAC7.html)
EP (1) EP1153017B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002537292A (cg-RX-API-DMAC7.html)
AT (1) ATE325105T1 (cg-RX-API-DMAC7.html)
AU (1) AU775208B2 (cg-RX-API-DMAC7.html)
CA (1) CA2362862A1 (cg-RX-API-DMAC7.html)
DE (1) DE60027700T2 (cg-RX-API-DMAC7.html)
DK (1) DK1153017T3 (cg-RX-API-DMAC7.html)
ES (1) ES2263447T3 (cg-RX-API-DMAC7.html)
PT (1) PT1153017E (cg-RX-API-DMAC7.html)
WO (1) WO2000049005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01010231A (es) * 1999-04-12 2003-07-21 Aventis Pharma Ltd Compuestos heteroarilo biciclicos sustituidos como antagonistas de integrina.
GB9908355D0 (en) * 1999-04-12 1999-06-09 Rhone Poulenc Rorer Ltd Chemical compounds
GB0001346D0 (en) * 2000-01-21 2000-03-08 Astrazeneca Uk Ltd Chemical compounds
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
CA2430978C (en) 2000-12-28 2012-05-15 Daiichi Pharmaceutical Co., Ltd. Vla-4 inhibitors
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
JP4676884B2 (ja) 2003-07-24 2011-04-27 第一三共株式会社 シクロヘキサンカルボン酸類
US7592373B2 (en) 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
DE10360745A1 (de) * 2003-12-23 2005-07-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
EP1737809B1 (en) * 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
DE102004017934A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7524862B2 (en) 2004-04-14 2009-04-28 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
US20070021612A1 (en) * 2004-11-04 2007-01-25 University Of Notre Dame Du Lac Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof
DE102006021878A1 (de) * 2006-05-11 2007-11-15 Sanofi-Aventis Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
UY32470A (es) 2009-03-05 2010-10-29 Boehringer Ingelheim Int Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones
US8759537B2 (en) 2010-08-20 2014-06-24 Boehringer Ingelheim International Gmbh 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
US8586604B2 (en) 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1
US8486968B2 (en) 2010-12-10 2013-07-16 Boehringer Ingelheim International Gmbh Compounds
US8466186B2 (en) 2010-12-10 2013-06-18 Boehringer Ingelheim International Gmbh Compounds
UY33779A (es) 2010-12-10 2012-07-31 Boehringer Ingelheim Int ?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas?

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025637A (en) 1973-10-23 1977-05-24 Lilly Industries, Ltd. 2,5 OR 2,6 Disubstituted benzoxazoles
US4100168A (en) 1974-09-20 1978-07-11 Lilly Industries Ltd. 2,5 OR 2,6-Disubstituted benzoxazoles
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
DE69706407T2 (de) * 1996-03-29 2002-05-29 G.D. Searle & Co., Chicago META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN
JPH10330369A (ja) 1997-04-04 1998-12-15 Sumitomo Pharmaceut Co Ltd 複素環化合物
GB9723789D0 (en) 1997-11-12 1998-01-07 Zeneca Ltd Chemical compounds
GB9916374D0 (en) * 1998-07-23 1999-09-15 Zeneca Ltd Chemical compounds
WO2000005223A2 (en) * 1998-07-23 2000-02-03 Astrazeneca Ab Heterocyclic derivatives and their use as integrin inhibitors

Similar Documents

Publication Publication Date Title
RU2008138649A (ru) Применение а1-агонистов аденозина и/или двойных а1/а2в-агонистов аденозина для получения лекарственных средств для лечения заболеваний
JP2014524934A5 (cg-RX-API-DMAC7.html)
JP2010510999A5 (cg-RX-API-DMAC7.html)
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
TWI262917B (en) 2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
NO331021B1 (no) Medikament for behandling av kreft omfattende kinolonderivater i kombinasjon med 5-FU eller CPT-11 samt anvendelse av derivatene
JP2017514809A5 (cg-RX-API-DMAC7.html)
JP2013532652A5 (cg-RX-API-DMAC7.html)
TW200608974A (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
JP2005511531A5 (cg-RX-API-DMAC7.html)
JP2008514732A5 (cg-RX-API-DMAC7.html)
RU2005106846A (ru) Производные бензотиазола, характеризующиеся агонистической активностью к бета-2-адренорецепторам
JP2011513475A5 (cg-RX-API-DMAC7.html)
CA2578596A1 (en) Substituted phenylaminothiazoles and their use
CA2668997A1 (en) 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
JP2004536869A5 (cg-RX-API-DMAC7.html)
TNSN07016A1 (en) Indole-2-carboxamidine derivatives as nmda receptor antagonists
RU2009132188A (ru) Режим дозирования ингибиторов комт
RU2013141559A (ru) Способ ингибирования клеток опухоли гамартомы
JP2023513797A5 (cg-RX-API-DMAC7.html)
JP2011526247A5 (cg-RX-API-DMAC7.html)
JP2005538111A5 (cg-RX-API-DMAC7.html)
JP2018502141A5 (cg-RX-API-DMAC7.html)
JP2007517007A5 (cg-RX-API-DMAC7.html)